[Federal Register Volume 72, Number 249 (Monday, December 31, 2007)]
[Notices]
[Page 74331]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-25329]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on December 10, 2007, Chattem 
Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, 
Tennessee 37409, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Oripavine (9330), a basic class of controlled substance listed in 
schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for sale to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a). Any such comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537; or any being sent via 
express mail should be sent to the Drug Enforcement Administration, 
Office of Diversion Control, Federal Register Representative (ODL), 
8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed 
no later than February 29, 2008.

    Dated: December 20, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-25329 Filed 12-28-07; 8:45 am]
BILLING CODE 4410-09-P